« Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway ». Nigerian Journal of Physiological Sciences 40, no. 2 (décembre 31, 2025): 251–262. Consulté le avril 14, 2026. https://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/4001.